EX-FILING FEES 5 ea023536101ex-fee_chinasxt.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-8

(Form Type)

 

China SXT Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type  Security Class
Title		  Fee
Calculation
Rule		  Amount
Registered(1) 		   Proposed
Maximum
Offering Price
Per Unit		   Maximum
Aggregate
Offering Price		   Fee Rate   Amount of
Registration Fee(2)  		 
Equity  ordinary shares with no par value (reserved for issuance under the 2025 equity incentive plan)  Other(3)   2,064,490   $2.72(3)   $5,615,413    0.00015310   $859.72 
Total Offering Amounts               $5,615,413    0.00015310   $859.72 
Total Fees Previously Paid                         — 
Total Fee Offsets                          — 
Net Fee Due                         $859.72 

 

(1) Pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such additional securities that may be offered pursuant to the terms of the China SXT Pharmaceuticals, Inc..
   
(2) The registrant does not have any fee offsets.
   
(3) Pursuant to Rule 457(h) and 457(c) promulgated under the Securities Act, solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for the registrant’s Ordinary Shares reserved for issuance under the registrant’s 2025 equity incentive plan is the average of the high and low prices of the registrant’s Ordinary Shares as reported on the Nasdaq Capital Market on March 27, 2025.